Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.27% is 60% below its 5-year average of 3.19%, near the low end of its 5-year range (0.42%–273.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 17.97% above its 12-month average of 1.08%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.27%.
DEBT TO ASSETS RATIO
1.27%
DEBT TO ASSETS RATIO AVG TTM
1.08%
DEBT TO ASSETS RATIO AVG 3Y
2.13%
DEBT TO ASSETS RATIO AVG 5Y
3.19%
DEBT TO ASSETS RATIO AVG 10Y
5.61%
DEBT TO ASSETS RATIO AVG 15Y
7.61%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+17.97%
CURRENT VS 3Y AVG
-40.25%
CURRENT VS 5Y AVG
-60.18%
CURRENT VS 10Y AVG
-77.36%
CURRENT VS 15Y AVG
-83.30%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 536 covered companies
CURRENT VS SECTOR MEDIAN
+1170.90%
vs the sector median at left
GlucoTrack, Inc.
Market Cap
$889929.00
Debt to Assets Ratio
1.27%
TTM Avg
1.08%
3Y Avg
2.13%
5Y Avg
3.19%
Market Cap
$875087.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$868982.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$814320.00
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.08M
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.11M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.18M
Debt to Assets Ratio
0.47%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GlucoTrack, Inc. (GCTK) | $889929.00 | 1.27% | 1.08% | 2.13% | 3.19% |
| Decoy Therapeutics Inc. (DCOY)vs › | $875087.00 | 0.00% | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $868982.00 | 0.00% | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $814320.00 | 0.01% | N/A | N/A | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | 0.00% | N/A | N/A | N/A |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | 0.11% | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $687644.00 | 0.38% | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | 0.10% | N/A | N/A | N/A |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.18M | 0.47% | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.20M | 0.56% | N/A | N/A | N/A |
Debt/Assets
1.3%
Debt/Equity
N/A
Current Ratio
0.46
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.27% |
| 2026-03-31 | 0.60% |
| 2025-12-31 | 0.42% |
| 2025-09-30 | 0.48% |
| 2025-06-30 | 2.62% |
| 2025-03-31 | 2.73% |
| 2024-12-31 | 4.50% |
| 2024-09-30 | 273.00% |
| 2024-06-30 | 49.18% |
| 2024-03-31 | 12.92% |
| 2023-12-31 | 4.00% |
| 2023-09-30 | 2.56% |
| 2023-06-30 | 2.10% |
| 2023-03-31 | 15.43% |
| 2022-12-31 | 8.00% |
| 2022-09-30 | 5.44% |
| 2022-06-30 | 4.45% |
| 2022-03-31 | 4.18% |
| 2021-12-31 | 3.99% |
| 2021-09-30 | 3.48% |
| 2021-06-30 | 3.45% |
| 2021-03-31 | 3.54% |
| 2020-12-31 | 3.42% |
| 2020-09-30 | 3.00% |
| 2020-06-30 | 2.48% |
| 2020-03-31 | 2.52% |
| 2019-12-31 | 34.49% |
| 2019-09-30 | 16.92% |
| 2019-06-30 | 11.58% |
| 2019-03-31 | 44.39% |
| 2018-12-31 | 24.44% |
| 2018-09-30 | 7.06% |
| 2018-06-30 | 11.43% |
| 2018-03-31 | 9.42% |
| 2017-12-31 | 10.95% |
| 2017-09-30 | 6.68% |
| 2017-06-30 | 5.26% |
| 2017-03-31 | 4.48% |
| 2016-12-31 | 6.58% |
| 2016-09-30 | 8.20% |
| 2016-06-30 | 5.91% |
| 2016-03-31 | 1.83% |
| 2015-12-31 | 7.52% |
| 2015-09-30 | 5.32% |
| 2015-06-30 | 4.01% |
| 2015-03-31 | 3.01% |
| 2014-12-31 | 9.73% |
| 2014-09-30 | 13.16% |
| 2014-06-30 | 68.48% |
| 2014-03-31 | 1.20% |
| 2013-12-31 | 25.15% |
| 2013-09-30 | 17.65% |
| 2013-06-30 | 14.22% |
| 2013-03-31 | 11.49% |
| 2012-12-31 | 4.59% |
| 2012-09-30 | 121.48% |
| 2012-06-30 | 57.07% |
| 2012-03-31 | 37.06% |
| 2011-12-31 | 27.77% |
| 2011-09-30 | 22.57% |
